Coexpression of multiple Sertoli cell and Leydig cell marker genes in the spontaneous testicular tumor of F344 rat: evidence for phenotypical bifurcation of the interstitial cell tumor.
The development of testicular tumor has been frequently observed in some laboratory rat strains. In the present study, we have further characterized the testicular tumor that spontaneously develops in the F344 rat (F344/Jcl). Tumor cells first appeared in the interstitium and developed into multifocal nodular lesions. In the later stage, the whole testes were occupied by tumor cells that consisted of three different types of cells in morphological appearance: large clear type, small eosinophilic type and intermediate type. To determine the character of these cells, we examined the expression of marker genes for Sertoli cells (e.g., transferrin) and Leydig cells (e.g., 3 beta-hydroxysteroid dehydrogenase 1 (3 beta-HSD 1)). Transferrin and 3 beta-HSD 1 mRNAs were found in all 8 tumor samples analyzed by northern blotting. By in situ hybridization, we observed a substantial amount of 3 beta-HSD 1 mRNA and little or no transferrin mRNA in the large clear cells. In contrast, the small eosinophilic cells showed little or no 3 beta-HSD 1 mRNA and a large amount of transferrin mRNA, suggesting that the tumor was a mixture of at least two types of cells. Other Sertoli cell marker genes, such as cyclic protein 2 and sulfated glycoprotein 2, were expressed in all 8 tumors analyzed, and testin and steel factor (SLF), the c-kit receptor ligand, were also expressed in some of the tumors (testin, 75%; SLF, 25%), while other Leydig cell markers, LH receptor and c-kit, were expressed in 87% and 80% of the tumors, respectively. These results indicate that the spontaneous testicular tumor of F344 rat is of interstitium origin, showing phenotypical bifurcation possibly via transdifferentiation.
Kondoh
G
G
Genome Information Research Center, Osaka University, Suita.
Yomogida
K
K
Dohmae
K
K
Nozawa
M
M
Koga
M
M
Nonomura
N
N
Miki
T
T
Okuyama
A
A
Nishimune
Y
Y
D015096:3-Hydroxysteroid Dehydrogenases / Q000096:biosynthesis; D000818:Animals; D056668:Cathepsin L; D002403:Cathepsins / Q000096:biosynthesis; D002454:Cell Differentiation; D051152:Clusterin; D003546:Cysteine Endopeptidases; D010450:Endopeptidases; D005819:Genetic Markers; D006023:Glycoproteins / Q000096:biosynthesis; D007985:Leydig Cells / Q000473:pathology*; D008297:Male; D018832:Molecular Chaperones; D009367:Neoplasm Staging; D014176:Protein Biosynthesis; D011506:Proteins; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011916:Rats, Inbred F344; D011974:Receptors, LH / Q000096:biosynthesis; D012708:Sertoli Cells / Q000473:pathology*; D019089:Stem Cell Factor / Q000096:biosynthesis; D013736:Testicular Neoplasms / Q000235:genetics* / Q000473:pathology*; D014158:Transcription, Genetic; D014168:Transferrin / Q000096:biosynthesis* / Q000235:genetics
D051152:Clusterin; D005819:Genetic Markers; D006023:Glycoproteins; D018832:Molecular Chaperones; D011506:Proteins; D012333:RNA, Messenger; D011974:Receptors, LH; D019089:Stem Cell Factor; D014168:Transferrin; C489180:testin protein, rat; D015096:3-Hydroxysteroid Dehydrogenases; D002403:Cathepsins; D010450:Endopeptidases; D003546:Cysteine Endopeptidases; D056668:Cathepsin L; C534280:Ctsl protein, rat